National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

iodine I 131 tositumomab (I-oh-dine I 131 TAH-sih-TOO-moh-mab)

 A monoclonal antibody (tositumomab) that has been chemically changed by adding radioactive iodine, and that is used in the treatment of certain types of non-Hodgkin lymphoma. It belongs to the family of drugs called radioconjugated monoclonal antibodies. When iodine I 131 tositumomab and tositumomab are given together, the combination is called the Bexxar regimen. Also called Bexxar regimen, tositumomab, and tositumomab and iodine I 131 tositumomab.



Previous Definitions:involuntary nervous system, iobenguane I 123, iodine, iodine I 131 metaiodobenzylguanidine, iodine I 131 monoclonal antibody BC8
Next Definitions:iododoxorubicin, ionizing radiation, ionomycin, IORT, IP

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov